Recent news and posts
Ongoing coverage positions by the Dutch Healthcare Institute
The Dutch Healthcare Institute performs health technology assessments to inform decisions about the coverage status of pharmaceutical and non-pharmaceutical medical technologies. Procedures are reviewed according to the criteria of necessity, effectiveness (conformity with “state of science and practice”), cost-effectiveness, and feasibility (later, only in case of review before the implementation of the method). The Ministry of Health, Welfare, and Sport makes a final coverage decision based on the recommendations provided by the ZIN.
As of October 2025, the Dutch Healthcare Institute (ZIN) is working on several coverage positions in the otorhinolaryngology, neurology, dental surgery, cardiovascular, and oncology fields, including the following Med Tech-related topics:
- Implantation of a second cochlear implant for adults with profound hearing loss or deafness;
- NightWatch® system for epilepsy;
- Vertebroplasty for painful vertebral metastases or multiple myeloma sites in the vertebrae;
- Transcatheter aortic valve implantation (TAVI) in patients with symptomatic severe aortic valve stenosis;
- Zygomatic implants in patients with a severely resorbed edentulous maxilla.
The full details in Dutch can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.